1. Home
  2. CAAS vs PEPG Comparison

CAAS vs PEPG Comparison

Compare CAAS & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CAAS

China Automotive Systems Inc.

HOLD

Current Price

$4.70

Market Cap

134.9M

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$2.95

Market Cap

121.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAAS
PEPG
Founded
N/A
2018
Country
China
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.9M
121.7M
IPO Year
2025
2022

Fundamental Metrics

Financial Performance
Metric
CAAS
PEPG
Price
$4.70
$2.95
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$11.17
AVG Volume (30 Days)
26.0K
1.0M
Earning Date
04-22-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.61
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.00
$1.13
52 Week High
$5.15
$7.80

Technical Indicators

Market Signals
Indicator
CAAS
PEPG
Relative Strength Index (RSI) 59.99 72.12
Support Level $4.38 $1.50
Resistance Level $4.91 $7.10
Average True Range (ATR) 0.21 0.21
MACD 0.03 0.10
Stochastic Oscillator 53.09 86.64

Price Performance

Historical Comparison
CAAS
PEPG

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm, through its subsidiary, is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series of power steering models, including rack and pinion power steering, integral power steering, electronic power steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: